BICO Group
47,2 SEK +5,1%1 investor følger denne virksomhed
BICO Group is active in medical technology. The company specializes in bio convergence and provides technology, products, and services for biology. With a focus on the application areas bioprinting, multi-omics, cell line development, and diagnostics, the company develops and markets technology that enables researchers to grow cells in 3D environments, conduct drug screening, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries.
Omsætning
2,25 mia.
EBIT %
-64,44 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BICO
Daglig lav / høj pris
44,17 / 48,5
SEK
Markedsværdi
3,33 mia. SEK
Aktieomsætning
10,56 mio. SEK
Volumen
229 t
Seneste videoer
Finanskalender
Delårsrapport
07.05.2024
Generalforsamling
20.05.2024
Delårsrapport
20.08.2024
Delårsrapport
13.11.2024
Årsrapport
19.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Erik Gatenholm | 13,6 % | 20,5 % |
Sartorius Lab Holding GmbH | 10,1 % | 8,5 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Founders leave after eight years
BICO Publishes Annual and Sustainability Report 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools